Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy

BACKGROUND: The global pandemic of type 2 diabetes mellitus (T2DM) is an enormous clinical and socioeconomic burden. Biguanides and DPP-4 inhibitors (DPP-4i) are the most commonly used therapies in Japanese T2DM patients. When glycemic control is not adequate despite combination of these drugs, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishihara, Hisamitsu, Anai, Motonobu, Seino, Hiroaki, Kitazawa, Toru, Ohashi, Hiroshi, Ai, Masumi, Inoue, Masahiro, Fujishiro, Midori, Inazawa, Takeshi, Kuroda, Hisamoto, Yamada, Masayo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167289/
https://www.ncbi.nlm.nih.gov/pubmed/30145651
http://dx.doi.org/10.1007/s13300-018-0491-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167289/
https://www.ncbi.nlm.nih.gov/pubmed/30145651
http://dx.doi.org/10.1007/s13300-018-0491-4

Ejemplares similares